JLHL Jupiter Life Line Hospitals Q4 FY25 results (Jan–Mar 2025) and concall
Jupiter Life Line Hospitals delivered strong FY25 results with significant revenue and EBITDA growth, driven by healthy ARPOB and occupancy rates. The company is actively pursuing its expansion strategy, with new bed additions in Indore and progress on greenfield projects in Dombivli and Pune. Strategic debt raising has bolstered liquidity, positioning the company for continued growth, though Q4 PAT saw a slight dip due to higher depreciation.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 270 | 274 |
| EBITDA | 69 | 72 |
| Net profit | 49 | 44 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
